| Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension A Boucly, J Weatherald, L Savale, X Jaïs, V Cottin, G Prevot, F Picard, ... European Respiratory Journal 50 (2), 2017 | 668 | 2017 |
| Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension J Weatherald, A Boucly, D Chemla, L Savale, M Peng, M Jevnikar, X Jaïs, ... Circulation 137 (7), 693-704, 2018 | 172 | 2018 |
| Chronic fatigue and postexertional malaise in people living with long COVID: an observational study R Twomey, J DeMars, K Franklin, SN Culos-Reed, J Weatherald, ... Physical therapy 102 (4), pzac005, 2022 | 154 | 2022 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... Cmaj 194 (7), E242-E251, 2022 | 136 | 2022 |
| Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension A Boucly, V Cottin, H Nunes, X Jaïs, A Tazi, G Prévôt, M Reynaud-Gaubert, ... European Respiratory Journal 50 (4), 2017 | 125 | 2017 |
| Cardiopulmonary exercise testing in pulmonary hypertension J Weatherald, S Farina, N Bruno, P Laveneziana Annals of the American Thoracic Society 14 (Supplement 1), S84-S92, 2017 | 114 | 2017 |
| Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study J Weatherald, MC Chaumais, L Savale, X Jaïs, A Seferian, M Canuet, ... European Respiratory Journal 50 (1), 2017 | 113 | 2017 |
| Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension A Boucly, L Savale, X Jaïs, F Bauer, E Bergot, L Bertoletti, A Beurnier, ... American journal of respiratory and critical care medicine 204 (7), 842-854, 2021 | 111 | 2021 |
| External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry A Boucly, J Weatherald, L Savale, P De Groote, V Cottin, G Prévot, ... European Respiratory Journal 59 (6), 2022 | 105 | 2022 |
| Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space J Weatherald, C Sattler, G Garcia, P Laveneziana European Respiratory Journal 51 (2), 2018 | 89 | 2018 |
| Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension J Weatherald, A Boucly, D Launay, V Cottin, G Prévot, D Bourlier, ... European Respiratory Journal 52 (4), 2018 | 83 | 2018 |
| Screening for pulmonary arterial hypertension in systemic sclerosis J Weatherald, D Montani, M Jevnikar, X Jaïs, L Savale, M Humbert European Respiratory Review 28 (153), 2019 | 81 | 2019 |
| Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial W Alhazzani, KKS Parhar, J Weatherald, Z Al Duhailib, M Alshahrani, ... Jama 327 (21), 2104-2113, 2022 | 78 | 2022 |
| Ion channels in pulmonary hypertension: a therapeutic interest? M Lambert, V Capuano, A Olschewski, J Sabourin, C Nagaraj, B Girerd, ... International journal of molecular sciences 19 (10), 3162, 2018 | 75 | 2018 |
| Tolerability and safety of awake prone positioning COVID-19 patients with severe hypoxemic respiratory failure K Solverson, J Weatherald, KKS Parhar Canadian Journal of Anaesthesia 68 (1), 64, 2021 | 74 | 2021 |
| Acute decompensated pulmonary hypertension L Savale, J Weatherald, X Jaïs, C Vuillard, A Boucly, M Jevnikar, ... European Respiratory Review 26 (146), 2017 | 69 | 2017 |
| Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension YU Taniguchi, X Jaïs, M Jevnikar, A Boucly, J Weatherald, P Brenot, ... The Journal of Heart and Lung Transplantation 38 (8), 833-842, 2019 | 67 | 2019 |
| Awake prone positioning for COVID-19 hypoxemic respiratory failure: a rapid review J Weatherald, K Solverson, DJ Zuege, N Loroff, KM Fiest, KKS Parhar Journal of Critical Care 61, 63, 2021 | 61 | 2021 |
| Association between BMI and obesity with survival in pulmonary arterial hypertension J Weatherald, A Huertas, A Boucly, C Guignabert, Y Taniguchi, Y Adir, ... Chest 154 (4), 872-881, 2018 | 60 | 2018 |
| The low-risk profile in pulmonary arterial hypertension. Time for a paradigm shift to goal-oriented clinical trial endpoints? J Weatherald, A Boucly, S Sahay, M Humbert, O Sitbon American journal of respiratory and critical care medicine 197 (7), 860-868, 2018 | 55 | 2018 |
Marc HumbertProfessor of Medicine, Université Paris-SaclayVerified email at aphp.fr
